ãã€ãªå»è¬åäŒæ¥ã® Protalix BioTherapeutics, Inc. ã¯ãã€ã¹ã©ãšã«ããã©ãžã«ãã©ãã³ã¢ã¡ãªã«ã®ãã®ä»ã®åœã
ãããã³äžçäžã§ãç¬èªã® ProCellEx æ€ç©çްèããŒã¹ã®ã¿ã³ãã¯è³ªçºçŸã·ã¹ãã ã«åºã¥ãçµã¿æãæ²»ççšã¿ã³ãã¯è³ªã®éçºãšåååã«æ³šåããŠããŸããå瀟ã¯ãŽãŒã·ã§ç
ã®æ²»çè¬ãšã㊠Elelyso ãæäŸããŠããŸãããã®è£œåãã€ãã©ã€ã³ã«ã¯ããã¡ããªãŒç
ã®æ²»çè¬ãšããŠç¬¬ III çžèšåºè©Šéšäžã®æ²»ççšã¿ã³ãã¯è³ªåè£ PRX-102ãå¢èæ§ç·ç¶çã®æ²»çè¬ãšããŠç¬¬ IIa çžèšåºè©Šéšãå®äºããç¬èªã®æ€ç©çްèçµã¿æãåããããªãã·ãªããã¯ã¬ã¢ãŒãŒ I ã§ãã PRX-110ãçé¢šã®æ²»çè¬ãšããŠæ€ç©çްèçºçŸãããçµã¿æã PEG åãŠãªã«ãŒãŒ PRX-115ãNET é¢é£çŸæ£ã®æ²»çè¬ãšããŠæ€ç©çްèçºçŸããã PEG åçµã¿æããã DNase I 補ååè£ PRX-119 ãå«ãŸããŸããå瀟ã¯ãã¡ã€ã¶ãŒãšå¥çŽããã³ææºFundação Oswaldo Cruz (Fiocruz)ãChiesi Farmaceutici SpA å瀟㯠1993 幎ã«èšç«ããããã¥ãŒãžã£ãŒãžãŒå·ããã±ã³ãµãã¯ã«æ ç¹ã眮ããŠããŸãã